Moxifloxacin in the Therapy of Experimental Pneumococcal Meningitis

The activity of moxifloxacin (BAY 12-8039) against a Streptococcus pneumoniae type 3 strain (MIC and minimum bactericidal concentration [MBC] of moxifloxacin, 0.06 and 0.25 μg/ml, respectively; MIC and MBC of ceftriaxone, 0.03 and 0.06 μg/ml, respectively) was determined in vitro and in a rabbit mod...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Schmidt, H., Dalhoff, A., Stuertz, K., Trostdorf, F., Chen, V., Schneider, O., Kohlsdorfer, C., Brück, W., Nau, R.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1998
主題:	Experimental Therapeutics
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105611/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9624483/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.6.1397
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!